Emcure reports robust growth driven by international markets and pipeline expansion

Emcure Pharmaceuticals sees 22.8% revenue growth amid strong overseas sales and pipeline progress, with expectations of stabilising domestic growth and advancing biologics innovation. Emcure Pharmaceuticals said revenue rose 22.8% year on year to ₹2,580 crore in the quarter ended June,…













